Barriers and Advances in Kidney Preservation

Author:

Steichen C.12,Giraud S.123,Bon D.12,Barrou B.1,Badet L.1,Salamé E.1,Kerforne T.14,Allain G.15,Roumy J.1,Jayle C.125,Hannaert P.12,Hauet T.12367ORCID,Thuillier R.1236ORCID

Affiliation:

1. Inserm U1082, Poitiers, F-86000, France

2. Université de Poitiers, Faculté de Médecine et de Pharmacie, Poitiers, F-86000, France

3. CHU de Poitiers, Service de Biochimie, Poitiers, F-86000, France

4. CHU de Poitiers, Département d’Anesthésie-Réanimation, Poitiers, F-86000, France

5. CHU de Poitiers, Service de Chirurgie Cardio-thoracique, Poitiers, F-86000, France

6. Fédération Hospitalo-Universitaire SUPORT, Poitiers, F-86000, France

7. IBiSA Plateforme ‘Plate-Forme MOdélisation Préclinique, Innovation Chirurgicale et Technologique (MOPICT)’, Domaine Expérimental du Magneraud, Surgères, F-17700, France

Abstract

Despite the fact that a significant fraction of kidney graft dysfunctions observed after transplantation is due to ischemia-reperfusion injuries, there is still no clear consensus regarding optimal kidney preservation strategy. This stems directly from the fact that as of yet, the mechanisms underlying ischemia-reperfusion injury are poorly defined, and the role of each preservation parameter is not clearly outlined. In the meantime, as donor demography changes, organ quality is decreasing which directly increases the rate of poor outcome. This situation has an impact on clinical guidelines and impedes their possible harmonization in the transplant community, which has to move towards changing organ preservation paradigms: new concepts must emerge and the definition of a new range of adapted preservation method is of paramount importance. This review presents existing barriers in transplantation (e.g., temperature adjustment and adequate protocol, interest for oxygen addition during preservation, and clear procedure for organ perfusion during machine preservation), discusses the development of novel strategies to overcome them, and exposes the importance of identifying reliable biomarkers to monitor graft quality and predict short and long-term outcomes. Finally, perspectives in therapeutic strategies will also be presented, such as those based on stem cells and their derivatives and innovative models on which they would need to be properly tested.

Publisher

Hindawi Limited

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine

Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3